Filing Details
- Accession Number:
- 0001140361-11-011700
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-23 20:02:04
- Reporting Period:
- 2011-02-18
- Filing Date:
- 2011-02-23
- Accepted Time:
- 2011-02-23 20:02:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1314052 | Anavex Life Sciences Corp. | AVXL | Services-Commercial Physical & Biological Research (8731) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1360545 | Harvey Lalach | 4837 Canyon Ridge Crescent Kelowna A1 V1W 4A1 | President Coo Secretary | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-02-18 | 3,000 | $3.75 | 597,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-02-18 | 1,628 | $3.74 | 595,372 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 600,000 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | stock options | $3.10 | 2008-06-03 | 2013-06-03 | 150,000 | 150,000 | Direct |
| Common Stock | stock options | $3.50 | 2010-06-29 | 2015-06-29 | 50,000 | 200,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2013-06-03 | 150,000 | 150,000 | Direct |
| 2015-06-29 | 50,000 | 200,000 | Direct |
Billionaire Hedge Funds
